MicroPort NeuroScientific Future Growth

Future criteria checks 5/6

MicroPort NeuroScientific is forecast to grow earnings and revenue by 25.3% and 22.1% per annum respectively. EPS is expected to grow by 25.4% per annum. Return on equity is forecast to be 16.7% in 3 years.

Key information

25.3%

Earnings growth rate

25.4%

EPS growth rate

Medical Equipment earnings growth	39.9%
Revenue growth rate	22.1%
Future return on equity	16.7%
Analyst coverage	Low
Last updated	06 Sep 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

SHSC:2172 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	1,466	418	327	364	2
12/31/2025	1,129	312	289	303	2
12/31/2024	868	236	258	235	2
6/30/2024	775	225	162	220	N/A
3/31/2024	720	185	137	187	N/A
12/31/2023	666	146	112	154	N/A
9/30/2023	653	140	145	182	N/A
6/30/2023	641	135	179	211	N/A
3/31/2023	594	56	177	217	N/A
12/31/2022	547	-22	176	224	N/A
9/30/2022	484	-67	121	183	N/A
6/30/2022	421	-112	66	141	N/A
3/31/2022	402	-44	83	149	N/A
12/31/2021	383	24	99	157	N/A
12/31/2020	222	45	13	47	N/A
12/31/2019	184	47	7	57	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2172's forecast earnings growth (25.3% per year) is above the savings rate (2.3%).

Earnings vs Market: 2172's earnings (25.3% per year) are forecast to grow faster than the Hong Kong market (12.4% per year).

High Growth Earnings: 2172's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 2172's revenue (22.1% per year) is forecast to grow faster than the Hong Kong market (7.4% per year).

High Growth Revenue: 2172's revenue (22.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2172's Return on Equity is forecast to be low in 3 years time (16.7%).

MicroPort NeuroScientific Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

MicroPort NeuroTech Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Recent updates

Investor sentiment improves as stock rises 16%

MicroPort NeuroScientific Corporation (SEHK:2172) commences an Equity Buyback Plan for 58,265,810 shares, representing 10% of its issued share capital, under the authorization approved on June 26, 2024.

MicroPort NeuroScientific Corporation (SEHK:2172) commences an Equity Buyback Plan for 58,265,810 shares, representing 10% of its issued share capital, under the authorization approved on June 26, 2024.

Upcoming dividend of HK$0.08 per share

First half 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.11 in 1H 2023)

MicroPort NeuroTech Limited to Report First Half, 2024 Results on Aug 28, 2024

Microport Neurotech Limited Announces Change of Company Secretary

MicroPort NeuroTech Limited Approves Final Dividend for the Year Ended 31 December 2023

MicroPort NeuroTech Limited, Annual General Meeting, Jun 26, 2024

MicroPort NeuroTech Limited Proposes Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 22 August 2024

MicroPort NeuroTech Limited to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Investor sentiment deteriorates as stock falls 22%

Investor sentiment deteriorates as stock falls 16%

MicroPort NeuroTech Limited Announces Executive Changes

First half 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.20 loss in 1H 2022)

MicroPort NeuroTech Limited to Report First Half, 2023 Results on Aug 30, 2023

MicroPort NeuroTech Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Full year 2022 earnings released: CN¥0.04 loss per share (vs CN¥0.049 profit in FY 2021)

Less than half of directors are independent

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies